(SH)
Hampton, PhD, MSN, RN, NEA-BC, CENP, FAONL, FACHE 2 , Jean Edward, PhD, RN 2 , Roberto Cardarelli, DO, MHA, MPH 3 1 UK HealthCare 2 UK College of Nursing 3 Saint Joseph Health Background
Characterization of genetic variants of GIPR reveals a contribution of -arrestin to metabolic phenotypes
Because SS-31 is cleared through the kidneys, patients taking nephrotoxic medications (certain antibiotics, chronic NSAID use) should discuss this with their provider before starting
Patients should look beyond phrases such as newly available, clinically tested or doctor recommended. Those statements may not explain the type of study performed, the products regulatory status or whether the evidence applies to the marketed use